Jerzy Dorosz

503 total citations
18 papers, 239 citations indexed

About

Jerzy Dorosz is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jerzy Dorosz has authored 18 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jerzy Dorosz's work include Epigenetics and DNA Methylation (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Jerzy Dorosz is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Jerzy Dorosz collaborates with scholars based in Denmark, Israel and Poland. Jerzy Dorosz's co-authors include Niels Chr. Nielsen, Raz Jelinek, Józef Dulak, Michael Gajhede, Agnieszka Łoboda, Sofiya Kolusheva, Thomas Vosegaard, Kresten Bertelsen, Grietje Molema and Agnieszka Jaźwa and has published in prestigious journals such as PLoS ONE, The Journal of Physical Chemistry B and Cancer Research.

In The Last Decade

Jerzy Dorosz

17 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerzy Dorosz Denmark 9 184 40 27 21 20 18 239
Grażyna Goch Poland 10 332 1.8× 27 0.7× 28 1.0× 22 1.0× 6 0.3× 16 486
Slim Azouzi France 9 147 0.8× 15 0.4× 72 2.7× 11 0.5× 14 0.7× 22 297
Greg Taylor United States 5 247 1.3× 11 0.3× 33 1.2× 12 0.6× 40 2.0× 6 344
Gregor Oemer Austria 7 216 1.2× 12 0.3× 33 1.2× 5 0.2× 10 0.5× 8 267
J Mikkelsen Denmark 8 261 1.4× 18 0.5× 26 1.0× 18 0.9× 13 0.7× 10 347
Manuela Gellert Germany 11 295 1.6× 22 0.6× 47 1.7× 28 1.3× 11 0.6× 22 443
Takamasa Yamaguchi Japan 11 100 0.5× 33 0.8× 29 1.1× 3 0.1× 19 0.9× 26 258
Peter Bowden Canada 17 402 2.2× 8 0.2× 40 1.5× 18 0.9× 28 1.4× 29 536
Yunfei Zhang China 9 123 0.7× 16 0.4× 17 0.6× 66 3.1× 26 1.3× 20 256
Mohsen Pourmousa United States 9 192 1.0× 15 0.4× 9 0.3× 22 1.0× 3 0.1× 12 271

Countries citing papers authored by Jerzy Dorosz

Since Specialization
Citations

This map shows the geographic impact of Jerzy Dorosz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerzy Dorosz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerzy Dorosz more than expected).

Fields of papers citing papers by Jerzy Dorosz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerzy Dorosz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerzy Dorosz. The network helps show where Jerzy Dorosz may publish in the future.

Co-authorship network of co-authors of Jerzy Dorosz

This figure shows the co-authorship network connecting the top 25 collaborators of Jerzy Dorosz. A scholar is included among the top collaborators of Jerzy Dorosz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerzy Dorosz. Jerzy Dorosz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Palladini, Arianna, Stine B. Clemmensen, Nicolaas A. Buijs, et al.. (2023). Abstract 687: Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis. Cancer Research. 83(7_Supplement). 687–687.
2.
Francotte, Pierre, Eric Goffin, Jerzy Dorosz, et al.. (2023). Exploring thienothiadiazine dioxides as isosteric analogues of benzo- and pyridothiadiazine dioxides in the search of new AMPA and kainate receptor positive allosteric modulators. European Journal of Medicinal Chemistry. 264. 116036–116036. 3 indexed citations
3.
Palladini, Arianna, Stine B. Clemmensen, Nicolaas A. Buijs, et al.. (2022). Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine. Biomedicines. 10(10). 2654–2654. 6 indexed citations
4.
Dorosz, Jerzy, Eric Goffin, Pierre Lestage, et al.. (2021). Development of Thiochroman Dioxide Analogues of Benzothiadiazine Dioxides as New Positive Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors. ACS Chemical Neuroscience. 12(14). 2679–2692. 17 indexed citations
5.
Krintel, Christian, Jerzy Dorosz, Andreas Haahr Larsen, et al.. (2020). Binding of a negative allosteric modulator and competitive antagonist can occur simultaneously at the ionotropic glutamate receptor GluA2. FEBS Journal. 288(3). 995–1007. 10 indexed citations
6.
Dorosz, Jerzy, Line H. Kristensen, Nanda G. Aduri, et al.. (2019). Molecular architecture of the Jumonji C family histone demethylase KDM5B. Scientific Reports. 9(1). 4019–4019. 21 indexed citations
7.
Larsen, Andreas Haahr, Jerzy Dorosz, Thor S. Thorsen, et al.. (2018). Small-angle neutron scattering studies on the AMPA receptor GluA2 in the resting, AMPA-bound and GYKI-53655-bound states. IUCrJ. 5(6). 780–793. 8 indexed citations
8.
Jones, Sarah E., et al.. (2018). Peptides Derived from Histone 3 and Modified at Position 18 Inhibit Histone Demethylase KDM6 Enzymes. ChemBioChem. 19(17). 1817–1822. 2 indexed citations
9.
Backe, Marie Balslev, Karl Bacos, Dan Ploug Christensen, et al.. (2017). Lysine demethylase inhibition protects pancreatic β cells from apoptosis and improves β-cell function. Molecular and Cellular Endocrinology. 460. 47–56. 19 indexed citations
10.
Dorosz, Jerzy, et al.. (2017). Expression, purification and characterization of the human MTA2-RBBP7 complex. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1865(5). 531–538. 6 indexed citations
11.
Dorosz, Jerzy, et al.. (2017). Structure‐Based Design of a New Scaffold for Cell‐Penetrating Peptidic Inhibitors of the Histone Demethylase PHF8. ChemBioChem. 18(14). 1369–1375. 5 indexed citations
12.
Kristensen, Line H., et al.. (2015). Structure and binding properties of a cameloid nanobody raised against KDM5B. Acta Crystallographica Section F Structural Biology Communications. 71(10). 1235–1241. 7 indexed citations
13.
Bertelsen, Kresten, et al.. (2012). Mechanisms of Peptide-Induced Pore Formation in Lipid Bilayers Investigated by Oriented 31P Solid-State NMR Spectroscopy. PLoS ONE. 7(10). e47745–e47745. 32 indexed citations
14.
Sheynis, Tania, et al.. (2011). Heparin Inhibits Membrane Interactions and Lipid‐Induced Fibrillation of a Prion Amyloidogenic Determinant. ChemBioChem. 12(5). 761–767. 8 indexed citations
15.
Dorosz, Jerzy, Yana Gofman, Sofiya Kolusheva, et al.. (2010). Membrane Interactions of Novicidin, a Novel Antimicrobial Peptide: Phosphatidylglycerol Promotes Bilayer Insertion. The Journal of Physical Chemistry B. 114(34). 11053–11060. 24 indexed citations
16.
Łoboda, Agnieszka, Anna Stachurska, Jerzy Dorosz, et al.. (2009). HIF-1 attenuates Ref-1 expression in endothelial cells: Reversal by siRNA and inhibition of geranylgeranylation. Vascular Pharmacology. 51(2-3). 133–139. 18 indexed citations
17.
Dorosz, Jerzy, et al.. (2009). Phospholipid-Induced Fibrillation of a Prion Amyloidogenic Determinant at the Air/Water Interface. Langmuir. 25(21). 12501–12506. 19 indexed citations
18.
Łoboda, Agnieszka, Agnieszka Jaźwa, Jerzy Dorosz, et al.. (2006). Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells. Atherosclerosis. 187(1). 26–30. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Grażyna Goch Breakdown of academic impact, for papers by Slim Azouzi Breakdown of academic impact, for papers by Greg Taylor Breakdown of academic impact, for papers by Gregor Oemer Breakdown of academic impact, for papers by J Mikkelsen Breakdown of academic impact, for papers by Manuela Gellert Breakdown of academic impact, for papers by Takamasa Yamaguchi Breakdown of academic impact, for papers by Peter Bowden Breakdown of academic impact, for papers by Yunfei Zhang Breakdown of academic impact, for papers by Mohsen Pourmousa
Rankless by CCL
2026